Regis Healthcare Ltd (ASX: REG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Regis Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.21 billion
P/E Ratio 116.28
Dividend Yield 3.41%
Shares Outstanding 301.03 million
Earnings per share -0.049
Dividend per share 0.13
Year To Date Return 26.24%
Earnings Yield 0.86%
Franking 50
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Regis Healthcare Ltd (ASX: REG)
    Latest News

    Modern accountant woman in a light business suit in modern green office with documents and laptop.
    Value Investing

    Looking for ASX value shares? Here's 1 I'd buy and 1 I'd avoid!

    It's not an easy exercise to identify which stocks are undervalued and which ones are simply terrible. Here's an example…

    Read more »

    Scientists working in the laboratory and examining results.
    Share Market News

    2 ASX healthcare shares with 'significant growth opportunities'

    This fund manager has named revealed some healthy opportunities.

    Read more »

    Three exuberant runners dash towards the camera. One raises her arms in triumph; another jumps in the air with arms raised. The third runner gives a satisfied smile.
    Small Cap Shares

    Catch 'em before it's too late: 3 ASX small-cap shares that just started soaring

    These stocks have risen in the last quarter, and NovaPort analysts reckon it's just the beginning.

    Read more »

    Young businesswoman sitting in kitchen and working on laptop.
    Small Cap Shares

    3 ASX small-cap shares with 'good growth potential as well as attractive dividend yields'

    These could be small caps to buy right now according to one fund manager.

    Read more »

    high share price
    Share Gainers

    Why Accent, Aussie Broadband, Regis Healthcare, and Wesfarmers shares are charging higher

    These ASX shares are avoiding the market weakness on Friday.

    Read more »

    Three businesspeople leap high with the CBD in the background.
    52-Week Highs

    3 ASX All Ords stocks hitting new 52-week highs while the market sinks

    The All Ordinaries Index is down 1.4%, but these three All Ords stocks are shaking off the selling pressure.

    Read more »

    A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
    Share Fallers

    'Bright outlook': 2 ASX shares now in a perfect dip for buying

    Experts name a pair of stocks that have plummeted in recent times but are worthy long-term investments.

    Read more »

    A young female investor sits in her home office looking at her ipad and smiling as she sees the QBE share price rising
    Share Market News

    3 ASX All Ords shares just upgraded by top brokers

    These three ASX All Ords shares just got upgraded by leading brokers.

    Read more »

    Three people in a corporate office pour over a tablet, ready to invest.
    Share Market News

    3 ASX All Ords directors buying up their company shares recently

    Should investors back these businesses if their leaders are?

    Read more »

    Three healthcare workers standing together and smiling.
    Earnings Results

    Here are 3 ASX healthcare share results you might have missed

    Regis Healthcare, EBOS and Neuren Pharmaceuticals are three ASX healthcare shares that just posted results. Here is what you need…

    Read more »

    Two mature-age people, a man and a woman, jump in unison with their arms and legs outstretched on a sunny beach.
    52-Week Highs

    Guess which 2 ASX All Ordinaries shares smashed 52-week highs amid today's carnage

    Here's what drove these shares to outperform on Tuesday.

    Read more »

    A man holds his hand out and yells for a train to wait for him on a train platform with the train in the background.
    Dividend Investing

    Want the dividends from these 5 ASX shares? You'd better be quick!

    These companies will go ex-div tomorrow.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    14 Mar 2024 $0.0628 50.00% Interim 11 Apr 2024
    12 Sep 2023 $0.0748 50.00% Final 27 Sep 2023
    16 Mar 2023 $0.0200 50.00% Interim 14 Apr 2023
    15 Sep 2022 $0.0232 50.00% Final 30 Sep 2022
    10 Mar 2022 $0.0352 50.00% Interim 08 Apr 2022
    15 Sep 2021 $0.0463 50.11% Final 30 Sep 2021
    10 Mar 2021 $0.0200 50.00% Interim 08 Apr 2021
    11 Mar 2020 $0.0402 50.00% Interim 30 Sep 2020
    11 Sep 2019 $0.0711 100.00% Final 26 Sep 2019
    13 Mar 2019 $0.0812 100.00% Interim 11 Apr 2019
    11 Sep 2018 $0.0865 100.00% Final 26 Sep 2018
    13 Mar 2018 $0.0928 100.00% Interim 11 Apr 2018
    01 Sep 2017 $0.0000 100.00% Final 18 Sep 2017
    03 Mar 2017 $0.1030 100.00% Interim 20 Mar 2017
    02 Sep 2016 $0.0594 100.00% Final 19 Sep 2016
    03 Mar 2016 $0.0940 100.00% Interim 21 Mar 2016
    03 Mar 2004 $0.0700 100.00% Interim 24 Mar 2004

    REG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Regis Healthcare Ltd

    Regis Healthcare Ltd provides residential care for the elderly in Australia, including respite, dementia-specific, and palliative care. The Company's principal activity is the provision of residential aged care services The firm's facilities are primarily located in metropolitan areas and a majority of its rooms offered are single bedrooms. The majority of Regis' revenue comes from government funding due to the highly regulated environment for aged care facilities in Australia, though the firm also receives resident fees.

    REG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $4.01 $-0.03 -0.74% 301,508 $4.04 $4.09 $3.97
    27 Mar 2024 $4.04 $-0.01 -0.25% 777,087 $4.06 $4.11 $3.96
    26 Mar 2024 $4.05 $0.07 1.76% 424,293 $4.04 $4.12 $3.93
    25 Mar 2024 $3.98 $-0.04 -1.00% 468,426 $4.03 $4.04 $3.97
    22 Mar 2024 $4.02 $0.02 0.50% 512,251 $3.99 $4.03 $3.92
    21 Mar 2024 $4.00 $0.06 1.52% 1,175,247 $3.93 $4.05 $3.93
    20 Mar 2024 $3.94 $0.11 2.87% 612,640 $3.73 $3.95 $3.71
    19 Mar 2024 $3.83 $-0.04 -1.03% 406,259 $3.88 $4.03 $3.78
    18 Mar 2024 $3.87 $-0.07 -1.78% 499,823 $3.96 $4.06 $3.85
    15 Mar 2024 $3.94 $-0.26 -6.19% 5,870,425 $4.18 $4.21 $3.94
    14 Mar 2024 $4.20 $-0.12 -2.78% 261,253 $4.27 $4.29 $4.20
    13 Mar 2024 $4.32 $0.32 8.00% 983,847 $4.08 $4.34 $4.08
    12 Mar 2024 $4.00 $0.17 4.44% 599,313 $3.91 $4.03 $3.87
    11 Mar 2024 $3.83 $0.03 0.79% 373,288 $3.80 $3.90 $3.79
    08 Mar 2024 $3.80 $-0.05 -1.30% 668,465 $3.85 $3.92 $3.79
    07 Mar 2024 $3.85 $0.09 2.39% 583,785 $3.78 $3.85 $3.76
    06 Mar 2024 $3.76 $0.06 1.62% 579,085 $3.71 $3.78 $3.66
    05 Mar 2024 $3.70 $0.04 1.09% 280,926 $3.64 $3.75 $3.63
    04 Mar 2024 $3.66 $0.17 4.87% 256,871 $3.52 $3.66 $3.52
    01 Mar 2024 $3.49 $-0.13 -3.59% 716,924 $3.65 $3.65 $3.47
    29 Feb 2024 $3.62 $-0.05 -1.36% 226,717 $3.67 $3.67 $3.58
    28 Feb 2024 $3.67 $0.10 2.80% 353,558 $3.57 $3.68 $3.54
    27 Feb 2024 $3.57 $-0.04 -1.11% 123,933 $3.63 $3.63 $3.48

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    06 Mar 2024 Jodie Leonard Buy 8,105 $29,988
    On-market trade.
    06 Mar 2024 Jodie Leonard Buy 5,400 $19,980
    On-market trade.
    20 Dec 2023 Linda Mellors Issued 333,838 $1,074,958
    Issue of securities. 869,139 Rights
    16 Oct 2023 Linda Mellors Buy 39,889 $100,520
    On-market trade. 535,301 Rights
    21 Sep 2023 Linda Mellors Exercise 42,163 $113,418
    Conversion of securities. 495,412 Rights
    21 Sep 2023 Linda Mellors Issued 42,163 $113,418
    Conversion of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Graham Hodges Non-Executive DirectorNon-Executive Chairman Aug 2017
    Mr Hodges has international experience in the financial services industry with a career spanning more than 40 years. He commenced his career in Commonwealth Treasury, Canberra, where he worked for 10 years before being seconded to the International Monetary Fund in Washington for several years. Graham built an executive career at the Australian and New Zealand Banking Group Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. He is member of Risk & Compliance Committee.
    Professor Christine Constance Bennett Non-Executive Director Mar 2018
    Professor Bennett has over 30 years of health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. Christine is also Convenor of the Champions of Change Coalition Health Group. Christine was awarded the title of Emeritus Professor at the University of Notre Dame Australia following her contributions as Deputy Vice Chancellor Enterprise & Partnerships and Dean of Medicine, Sydney for more than 10 years. She is Chair of the Clinical Governance and Care Committee, Member of the Risk and Compliance Committee as well as Property Committee.
    Mr Bryan Dorman Non-Executive Director May 2007
    Mr Dorman has experience working in and growing enterprises across range of industry sectors, including residential aged care, manufacturing, property development, asset investment and business services. Bryan was a Partner in Melbourne accounting firm Rees Partners from 1977 until 2000. He is Member of the Risk and Compliance Committee and Clinical Governance and Care Committee.
    Mr Ian Gregory Roberts Non-Executive Director May 2007
    Mr Roberts has over 30 years of experience in the real estate sector including in excess of 20 years in residential aged care. Prior to co-leading the Regis journey, Ian was involved in property development (sub-divisional and commercial) in South East Queensland. As a founding shareholder and Director of Regis (Executive Director prior to 2008), Ian headed up Property with oversight of the development and implementation of the strategy that saw the business grow to more than 4,500 beds nationally. He is Chair of Property Committee.
    Ms Jodie Lee Leonard Non-Executive Director Nov 2023
    Mr Leonard is currently a non-executive director at ASX-listed Pacific Smiles Group Ltd (ASX:PSQ) and XPON Technologies Group Ltd (ASX:XPN) and in both cases chairs their Nomination and Remuneration Committees. Jodie is also a non-executive director of Barwon Region Water Corporation, a water utility company in Geelong, Victoria.
    Dr Linda Jane Mellors Chief Executive OfficerManaging Director Aug 2019
    Dr Mellors has over 20 years of executive experience in health and aged care. Prior to joining Regis, Linda held a range of roles in hospital and health systems predominantly in Victoria, as well as a national aged care service. Linda was also the Co-Chair of the Victorian Metropolitan Hospital Chief Executive group.
    Ms Sally Margaret Freeman Non-Executive Director Jan 2022
    Ms Freeman Chairs Regis Audit, Risk and Compliance Committee. She has experience in governance, risk and audit, with a career spanning over 30 years, culminating in being the Partner in Charge of KPMG Australia's Risk Consulting practice and representing that practice on the international Board. She is Member of the Clinical Governance and Care Committee.
    Mr Malcolm Peter Ross Company SecretaryGeneral Counsel Nov 2021
    -
    Rick Rostolis Chief Financial Officer
    -
    Imtiaz Bhayat Chief Information Officer
    -
    Carolyn Noumertzis Chief People Officer
    -
    Malcolm Peter Ross Company SecretaryGeneral Counsel
    -
    Melissa McDonald Executive General Manager - Clinical and Care Practice
    -
    Michael Horwood Executive General Manager - Property
    -
    Filomena Ciavarella Executive General Manager - Strategy Quality and Improvement
    -
    Gregg Funston Executive General Manager Operations
    -
    James Theofanis Executive General Manager Operations
    -
    Michelle Martella Executive General Manager Support Services
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Ashburn Pty Ltd 81,910,479 27.22%
    Galabay Pty Ltd 81,910,479 27.22%
    Citicorp Nominees Pty Limited 32,457,153 10.79%
    National Nominees Limited 26,166,710 8.70%
    Buttonwood Nominees Pty Ltd 13,821,392 4.59%
    J P Morgan Nominees Australia Pty Limited 12,853,545 4.27%
    Mandala Holdings Pty Ltd 3,786,200 1.26%
    HSBC Custody Nominees (Australia) Limited 3,707,979 1.23%
    Bnp Paribas Noms Pty Ltd 2,815,335 0.94%
    Mr Vincent Michael O'Sullivan 1,811,300 0.60%
    Bki Investment Company Limited 1,807,428 0.60%
    Netwealth Investments Limited 1,707,139 0.57%
    UBS Nominees Pty Ltd 1,654,330 0.55%
    Mr Ross James Johnston 1,350,000 0.45%
    Mrs Julia Michelle Manken & Mr Mike Darren Manken & Miss Jessica Kelly Manken 1,335,000 0.44%
    Ballian Investments Pty Ltd 787,934 0.26%
    Canto Holdings Pty Ltd 785,548 0.26%
    Netwealth Investments Limited i 700,857 0.23%
    BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd 667,638 0.22%
    Bertalli Family Foundation Pty Ltd 600,000 0.20%
    Culloden Investments Pty Ltd 600,000 0.20%
    Neweconomy Com Au Nominees Pty Limited 535,792 0.18%

    Profile

    since

    Note